![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
Inspire Pharmaceuticals |
---|---|
Information provided by: | Inspire Pharmaceuticals |
ClinicalTrials.gov Identifier: | NCT00403975 |
The purpose of this trial is to assess the effectiveness and safety of 2% diquafosol tetrasodium ophthalmic solution versus placebo following 6 weeks of treatment in subjects with mild to moderate dry eye disease.
Condition | Intervention | Phase |
---|---|---|
Dry Eye Disease |
Drug: diquafosol tetrasodium ophthalmic solution, 2% |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Multi-Center, Parallel Group, Double-Masked, Randomized, Placebo-Controlled Study of Multiple Ocular Instillations of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 03-109 |
Study First Received: | November 22, 2006 |
Last Updated: | November 24, 2006 |
ClinicalTrials.gov Identifier: | NCT00403975 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Eye Diseases |
Eye Diseases |